Steven Denbaars

Steven Denbaars, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Akoustis Technologies, Inc., Aeluma, Inc. and Palomino Laboratories Inc. The record holds 26 filings, for trades running from 22 June 2021 to 27 August 2026.

In open-market terms, that means 1 purchase worth €42k on one side and 16 sales worth €1.5M on the other. On balance, insiders were net sellers of €1.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 6 share grants and 1 option exercise. So far in 2026, the count stands at 1 purchase and 9 sales.

The latest filing, published on 28 August 2026, reports an open-market sale of €148k in Aeluma, Inc. The most recent open-market purchase was published on 20 April 2026, 181 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.